TECH
Bio-Techne CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.55B
P/E Ratio
68.87
EPS
$0.70
Beta
1.41
52W High
$71.93
52W Low
$43.12
50-Day MA
$52.31
200-Day MA
$57.60
Dividend Yield
0.68%
Profit Margin
9.05%
Forward P/E
23.64
PEG Ratio
0.66
About Bio-Techne Corp
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
Fundamentals
| Revenue (TTM) | $1.21B |
| Gross Profit (TTM) | $803.97M |
| EBITDA | $366.05M |
| Operating Margin | 25.20% |
| Return on Equity | 5.34% |
| Return on Assets | 7.45% |
| Revenue/Share (TTM) | $7.77 |
| Book Value | $12.90 |
| Price-to-Book | 3.62 |
| Price-to-Sales (TTM) | 6.23 |
| EV/Revenue | 6.3 |
| EV/EBITDA | 29.67 |
| Quarterly Earnings Growth (YoY) | 128.60% |
| Quarterly Revenue Growth (YoY) | -1.50% |
| Shares Outstanding | $156.57M |
| Float | $154.66M |
| % Insiders | 0.30% |
| % Institutions | 117.84% |
Historical Volatility
HV 10-Day
44.25%
HV 20-Day
84.03%
HV 30-Day
79.13%
HV 60-Day
60.91%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($61.42 target)
1
Strong Buy9
Buy4
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026